Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

Frank G. Schaap; Peter L. M. Jansen; Steven W. M. Olde Damink

doi:10.1002/hep.29511

Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

Frank G. Schaap^*, Peter L. M. Jansen, Steven W. M. Olde Damink

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	782-784
Number of pages	3
Journal	Hepatology
Volume	67
Issue number	2
DOIs	https://doi.org/10.1002/hep.29511
Publication status	Published - Feb 2018

Keywords

FATTY LIVER-DISEASE
HEPATOCELLULAR-CARCINOMA
HEPATOCARCINOGENESIS

Access to Document

10.1002/hep.29511Licence: CC BY

Full TextFinal published version, 557 KBLicence: Taverne

Cite this

@article{298fa083cb84425e87f609e0b0a50904,

title = "Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?",

keywords = "FATTY LIVER-DISEASE, HEPATOCELLULAR-CARCINOMA, HEPATOCARCINOGENESIS",

author = "Schaap, {Frank G.} and Jansen, {Peter L. M.} and Damink, {Steven W. M. Olde}",

year = "2018",

month = feb,

doi = "10.1002/hep.29511",

language = "English",

volume = "67",

pages = "782--784",

journal = "Hepatology",

issn = "0270-9139",